Bausch Health Companies (BHC): Director bought ~$5.39M
John Paulson, Director at Bausch Health Companies, bought ~$5.39M of Bausch Health Companies shares.
- ~$5.39M
- Approx. value · 1.03M sh @ $5.24
- 28.2M
- Holds after · shares reported
- Traded
- Jun 11, 2025
- Filed
- Jun 13, 2025
What stands out in this filing
- The purchase added 3.8% to the shares this insider held before it; the filing reports 28,222,267 shares, held indirectly afterwards.
- 1,029,098 shares at an average of $5.24 each, as reported on the form.
- The first open-market purchase by this insider in 0 months.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 10, 2025InsiderDirector purchased ~$3.81M of BHC shares in the open market
- Jun 11, 2025 · this disclosureInsiderDirector purchased ~$5.39M of BHC shares in the open market
What came next
- Jun 12, 2025InsiderDirector purchased ~$5.5M of BHC shares in the open market
- Jun 13, 2025InsiderDirector purchased ~$21.2M of BHC shares in the open market
- Aug 11, 2025InsiderDirector purchased ~$12.7M of BHC shares in the open market
- Aug 12, 2025InsiderDirector purchased ~$7.96M of BHC shares in the open market
- Aug 13, 2025InsiderDirector purchased ~$610K of BHC shares in the open market
- Aug 14, 2025InsiderDirector purchased ~$312M of BHC shares in the open market
- Aug 21, 2025InsiderDirector sold ~$122K of BHC shares in the open market
- Sep 8, 2025InsiderOfficer sold ~$98K of BHC shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Bausch Health Companies
For Bausch Health Companies, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BHC page.
Other recent filings by John Paulson, Director
- SEC Form 4 at Bausch Health Companies (BHC)Aug 15, 2025
- SEC Form 4 at Bausch Health Companies (BHC)Aug 13, 2025
- SEC Form 4 at Bausch Health Companies (BHC)Aug 13, 2025
- SEC Form 4 at Bausch Health Companies (BHC)Aug 13, 2025
- SEC Form 4 at Bausch Health Companies (BHC)Jun 17, 2025
The full history of John Paulson, Director is on the profile page.
How this filing works
Explore the data
Common questions
Which Bausch Health Companies (BHC) insider traded, and how much?
John Paulson, Director at Bausch Health Companies, bought ~$5.39M of Bausch Health Companies shares. 1.03M shares at $5.24, open market.
When did it happen, and when was it made public?
Traded: Jun 11, 2025. Filed: Jun 13, 2025. That is 2 days between the two dates.
What stands out in this filing?
The purchase added 3.8% to the shares this insider held before it; the filing reports 28,222,267 shares, held indirectly afterwards. 1,029,098 shares at an average of $5.24 each, as reported on the form. The first open-market purchase by this insider in 0 months.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Bausch Health Companies recently?
For Bausch Health Companies, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BHC page.
Does this mean BHC stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Bausch Health Companies
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRFeb 17, 2026
- SEC Form 13F-HRFeb 17, 2026
Everything OQRO holds on this company is on its BHC page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
